Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisMorie A. Gertz, G Grateau, Ray Comenzo et al.|American Journal of Hematology|2005Cited by 1.4k
International Myeloma Working Group molecular classification of multiple myeloma: spotlight reviewRafaël Fonseca, Hervé Avet‐Loiseau, P. Leif Bergsagel et al.|Leukemia|2009Cited by 877
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaAntonio Palumbo, Paul G. Richardson, Jesús F. San Miguel et al.|Leukemia|2007Cited by 839
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disordersAngela Dispenzieri, Robert A. Kyle, Giampaolo Merlini et al.|Leukemia|2008Cited by 808
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group studyShaji Kumar, J H Lee, Juan José Lahuerta et al.|Leukemia|2011Cited by 721